AB, R., EJ, N., TM, A., AC, O., D, B., C, C., . . . T, A. (2022). Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever. Clinical and experimental vaccine research, 11(3), 249. https://doi.org/10.7774/cevr.2022.11.3.249
Chicago Style (17th ed.) CitationAB, Rowaiye, Nwonu EJ, Asala TM, Ogu AC, Bur D, Chukwu C, Oli AN, and Agbalalah T. "Identifying Immunodominant Multi-epitopes from the Envelope Glycoprotein of the Lassa Mammarenavirus as Vaccine Candidate for Lassa Fever." Clinical and Experimental Vaccine Research 11, no. 3 (2022): 249. https://doi.org/10.7774/cevr.2022.11.3.249.
MLA (9th ed.) CitationAB, Rowaiye, et al. "Identifying Immunodominant Multi-epitopes from the Envelope Glycoprotein of the Lassa Mammarenavirus as Vaccine Candidate for Lassa Fever." Clinical and Experimental Vaccine Research, vol. 11, no. 3, 2022, p. 249, https://doi.org/10.7774/cevr.2022.11.3.249.